- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03768323
Airtime Incentive Amounts to Improve Interactive Voice Response Surveys in Bangladesh and Uganda
December 6, 2018 updated by: Johns Hopkins Bloomberg School of Public Health
A Randomized Controlled Trial of Varying Airtime Incentive Amounts to Improve Interactive Voice Response (IVR) Survey Performance in Bangladesh and Uganda
This study evaluates the effect of two different airtime incentive amounts on interactive voice response (IVR) survey cooperation, response, refusal, and contact rates, as compared to control group, in Bangladesh and Uganda.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Using random digit dialing sampling techniques, the investigators randomized random digit dialed (RDD) participants to one of three airtime incentive amounts contingent on them completing the noncommunicable disease risk factor survey.
This mobile phone survey was sent as an interactive voice response (IVR).
In IVR surveys, participants use their touch tone key pad to answer pre-recorded questions.
(i.e.
If you are male, press 1; If you are female, press 2).
This study was conducted in both Bangladesh and Uganda
Study Type
Interventional
Enrollment (Actual)
4233
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Dhaka, Bangladesh
- Institute of Epidemiology Disease Control and Research
-
-
-
-
-
Kampala, Uganda
- Makerere University School of Public Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Access to a mobile phone
- Greater or equal to 18 years of age
- In Bangladesh, conversant in either English or Bangla language. In Uganda, conversant in either Luo, Luganda, Runyakitara, or English Languages
Exclusion Criteria:
- Less than 18 years of age
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
NO_INTERVENTION: Control
No airtime incentive was given for completing the survey
|
|
EXPERIMENTAL: 1X incentive
1X airtime incentive
|
an incentive given in the form of airtime to motivate participants to complete the survey.
Participants were given 50 Bangladeshi Taka ($0.60 USD) or 5000 Ugandan Shillings (UGX; $1.35 USD as of April 3, 2018) worth of airtime for completing the survey
|
EXPERIMENTAL: 2X incentive
2X airtime incentive
|
an incentive given in the form of airtime to motivate participants to complete the survey.
Participants were given 100 Bangladeshi Taka ($1.20 USD) or 10000 UGX ($2.70 USD) worth of airtime for completing the survey
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cooperation Rate #1
Time Frame: Through study completion, an average of one month
|
As defined by American Association for Public Opinion Research,the number of complete interviews divided by the sum of complete interviews, partial interviews, refusals, and breakoffs
|
Through study completion, an average of one month
|
Response Rate #4
Time Frame: Through study completion, an average of one month
|
As defined by American Association for Public Opinion Research,the number of complete and partial interviews divided by the sum of complete interviews, partial interviews, refusals, breakoffs, and the estimated eligible proportion of unknowns
|
Through study completion, an average of one month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Refusal Rate #2
Time Frame: Through study completion, an average of one month
|
As defined by American Association for Public Opinion Research,the number of refusals and break-offs divided by the number of complete interviews, partial interviews, refusals, breakoffs, and the estimated eligible proportion of unknowns
|
Through study completion, an average of one month
|
Contact Rate #2
Time Frame: Through study completion, an average of one month
|
As defined by American Association for Public Opinion Research,the number of complete and partial interviews, refusals and break-offs divided by the number of complete interviews, partial interviews, refusals, breakoffs, and the estimated eligible proportion of unknowns
|
Through study completion, an average of one month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Adnan A Hyder, Phd, MBBS, Johns Hopkins Bloomberg School of Public Health
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Gibson DG, Pariyo GW, Wosu AC, Greenleaf AR, Ali J, Ahmed S, Labrique AB, Islam K, Masanja H, Rutebemberwa E, Hyder AA. Evaluation of Mechanisms to Improve Performance of Mobile Phone Surveys in Low- and Middle-Income Countries: Research Protocol. JMIR Res Protoc. 2017 May 5;6(5):e81. doi: 10.2196/resprot.7534.
- Gibson DG, Pereira A, Farrenkopf BA, Labrique AB, Pariyo GW, Hyder AA. Mobile Phone Surveys for Collecting Population-Level Estimates in Low- and Middle-Income Countries: A Literature Review. J Med Internet Res. 2017 May 5;19(5):e139. doi: 10.2196/jmir.7428.
- Gibson DG, Farrenkopf BA, Pereira A, Labrique AB, Pariyo GW. The Development of an Interactive Voice Response Survey for Noncommunicable Disease Risk Factor Estimation: Technical Assessment and Cognitive Testing. J Med Internet Res. 2017 May 5;19(5):e112. doi: 10.2196/jmir.7340.
- Hyder AA, Wosu AC, Gibson DG, Labrique AB, Ali J, Pariyo GW. Noncommunicable Disease Risk Factors and Mobile Phones: A Proposed Research Agenda. J Med Internet Res. 2017 May 5;19(5):e133. doi: 10.2196/jmir.7246.
- Gibson DG, Wosu AC, Pariyo GW, Ahmed S, Ali J, Labrique AB, Khan IA, Rutebemberwa E, Flora MS, Hyder AA. Effect of airtime incentives on response and cooperation rates in non-communicable disease interactive voice response surveys: randomised controlled trials in Bangladesh and Uganda. BMJ Glob Health. 2019 Sep 6;4(5):e001604. doi: 10.1136/bmjgh-2019-001604. eCollection 2019.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
March 26, 2017
Primary Completion (ACTUAL)
July 14, 2017
Study Completion (ACTUAL)
July 14, 2017
Study Registration Dates
First Submitted
August 1, 2018
First Submitted That Met QC Criteria
December 5, 2018
First Posted (ACTUAL)
December 7, 2018
Study Record Updates
Last Update Posted (ACTUAL)
December 10, 2018
Last Update Submitted That Met QC Criteria
December 6, 2018
Last Verified
December 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 00007318
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Noncommunicable Diseases
-
Azienda Sanitaria Locale CN2 Alba-BraUniversity of Eastern Piedmont; Eclectica Sas di Beccaria Franca, Ermacora...CompletedMajor Risk Factors for Noncommunicable DiseasesItaly
-
University of OxfordMahidol Oxford Tropical Medicine Research Unit; Chiang Rai Clinical Research... and other collaboratorsCompletedInfections | Risk Factors | Health Status | Noncommunicable DiseaseBangladesh, Cambodia, Myanmar, Thailand
-
Martina HorvatActive, not recruitingNoncommunicable Diseases | Vulnerable ElderlySlovenia
-
The University of Hong KongCompletedNon-communicable DiseasesHong Kong
-
Unidad de Cirugía CardiovascularWashington University School of Medicine; International Development Research...CompletedNon-communicable DiseasesGuatemala
-
Johns Hopkins Bloomberg School of Public HealthMakerere University; The Bloomberg Family Foundation, Inc.; Institute of Epidemiology...CompletedNoncommunicable Diseases | Surveys and QuestionnairesBangladesh, Uganda
-
Johns Hopkins Bloomberg School of Public HealthMakerere University; Institute of Epidemiology, Disease Control and ResearchCompletedNoncommunicable Diseases | Surveys and QuestionnairesBangladesh, Uganda
-
Johns Hopkins Bloomberg School of Public HealthMakerere University; The Bloomberg Family Foundation, Inc.; Institute of Epidemiology...CompletedNoncommunicable Diseases | Surveys and QuestionnairesBangladesh, Uganda
-
Johns Hopkins Bloomberg School of Public HealthIfakara Health InstituteCompletedNoncommunicable Diseases | Surveys and QuestionnairesTanzania
-
Johns Hopkins Bloomberg School of Public HealthIfakara Health Institute; Pontificia Universidad Javeriana; The Bloomberg Family...CompletedNoncommunicable Diseases | Surveys and QuestionnairesTanzania, Colombia
Clinical Trials on 1X airtime incentive
-
Johns Hopkins Bloomberg School of Public HealthIfakara Health Institute; Pontificia Universidad Javeriana; The Bloomberg Family...CompletedNoncommunicable Diseases | Surveys and QuestionnairesTanzania, Colombia
-
Johns Hopkins Bloomberg School of Public HealthIfakara Health Institute; Pontificia Universidad Javeriana; The Bloomberg Family...CompletedNoncommunicable Diseases | Surveys and QuestionnairesTanzania, Colombia
-
Johns Hopkins Bloomberg School of Public HealthMakerere University; The Bloomberg Family Foundation, Inc.; Institute of Epidemiology...CompletedNoncommunicable Diseases | Surveys and QuestionnairesBangladesh, Uganda
-
Merck Sharp & Dohme LLCCompletedPneumococcal Infections | Streptococcus Pneumoniae Infection
-
University of MelbourneAlcon Research; Clinical Vision Research AustraliaCompletedMyopia | HyperopiaAustralia
-
HepNet Study House, German LiverfoundationCompletedImmunocompromised | TransplantedGermany
-
Next Science TMSkin Laser & Surgery SpecialistsTerminatedAcne VulgarisUnited States
-
Emory UniversityCompleted
-
University of PennsylvaniaCompleted
-
University of PennsylvaniaDeloitteCompletedObesityUnited States